Search

… SK 923 Description Capan-1 is a human pancreatic ductal adenocarcinoma cell line. These cells grow in adherent tissue culture and display epithelial morphology. In culture, these cells are capable of invading through an extracellular matrix, such as Matrigel. The Capan-1 cells are resistant to 5-fluorouracil

… Job Title Research Technician Start Year 2023 Email [email protected] Lab Phone (646) 888-2649

I am a radiologist who specializes in breast imaging, percutaneous breast biopsy, and body oncologic imaging. My expertise includes the interpretation of mammography, breast ultrasound, and breast MRI.

… Radiologist Job Title Attending Radiologist I am a radiologist who specializes in breast imaging, percutaneous breast biopsy, and body oncologic imaging. My expertise includes the interpretation of mammography, breast ultrasound, and breast MRI. Read more I am also expert in the use of minimally invasive

Soy radióloga especializada en imagenología mamaria, biopsia de mama percutánea e imagenología corporal oncológica. Mi experiencia incluye la interpretación de mamografías, ecografías mamarias y resonancia magnética de mama.

… Radiologist Job Title Radióloga adjunta asociada Soy radióloga especializada en imagenología mamaria, biopsia de mama percutánea e imagenología corporal oncológica. Mi experiencia incluye la interpretación de mamografías, ecografías mamarias y resonancia magnética de mama. Read more También soy experta

Researchers gain insight into leptomeningeal metastasis, a devastating complication of advanced cancer.

… Friday, July 17, 2020 Summary Cancer that has spread to the fluid and tissues of the brain and spinal cord, called leptomeningeal metastasis , is difficult to treat. It was not clear how the cancer cells survive in this space. A new discovery shows the cancer cells reprogram themselves to outcompete

Memorial Sloan Kettering Cancer Center (MSK) and Curadev Pharma, Inc., a biotechnology company developing novel immuno-oncology therapeutics, are expanding their collaboration through the MSK Therapeutics Accelerator program to advance the development of CRD3874-SI, Curadev’s first-in-class allosteric stimulator of interferon genes (STING) agonist for solid tumors.

… Friday, June 20, 2025 Memorial Sloan Kettering Cancer Center (MSK) and Curadev Pharma, Inc., a biotechnology company developing novel immuno-oncology therapeutics, are expanding their collaboration through the MSK Therapeutics Accelerator program to advance the development of CRD3874-SI, Curadev’s first-in-class

… SK1980-535 Description SK-HEP-1 is an immortal, human hepatic adenocarcinoma cell line that grows in adherent culture. This cell line is capable of forming tumors in immunocompromised mice. SK-HEP-1 cells in culture have been shown to produce fibronectin and functionally active alpha-1 protease inhibitor

… Job Title Research Technician

Minimally invasive techniques, improved postoperative care, and a multidisciplinary approach help make Memorial Sloan Kettering Cancer Center’s rates of esophageal surgical morbidity and mortality among the country’s lowest.

… Friday, September 23, 2016 At Memorial Sloan Kettering Cancer Center (MSK), we have made significant strides in the management of esophageal cancer over the past ten years. Improvements in postoperative care and the introduction of minimally invasive techniques have decreased the number of postoperative